Market closed

Insulet/$PODD

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Insulet

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

Ticker

$PODD
Trading on

Industry

Health Care Equipment & Supplies

Employees

3,000

Insulet Metrics

BasicAdvanced
$19B
Market cap
48.07
P/E ratio
$5.74
EPS
1.22
Beta
-
Dividend rate
$19B
1.22
$267.30
$156.00
509K
3.676
2.525
125.152
128.909
8.17%
7.57%
48.79%
48.067
9.728
17.29
20
88.446
27.42%
232.93%
24.13%
135.20%

What the Analysts think about Insulet

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Insulet stock.

Insulet Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Insulet Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PODD

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Insulet stock?

Insulet (PODD) has a market cap of $19B as of November 13, 2024.

What is the P/E ratio for Insulet stock?

The price to earnings (P/E) ratio for Insulet (PODD) stock is 48.07 as of November 13, 2024.

Does Insulet stock pay dividends?

No, Insulet (PODD) stock does not pay dividends to its shareholders as of November 13, 2024.

When is the next Insulet dividend payment date?

Insulet (PODD) stock does not pay dividends to its shareholders.

What is the beta indicator for Insulet?

Insulet (PODD) has a beta rating of 1.22. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.